Dyno Therapeutics Stock
Dyno Therapeutics is developing an AI-powered biotechnology platform to create novel gene therapies. Its technology combines next-generation DNA synthesis, AAV capsid engineering, and machine learning to optimize gene delivery vectors, enabling more effective and safer gene therapies.
Founded: 2018
For more Dyno Therapeutics stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Eric Kelsic Co-Founder & Chief Executive Officer |
| Adrian Veres Co-Founder & Chief Scientific Officer |
| Tomas Bjorklun Co-Founder & Scientific Advisor |
| George Church Co-Founder & Scientific Advisor |
| Alan Crane Co-Founder & Chairman |
